Why the study?
Epicardial adipose tissue may contribute to the accelerated plaque burden, high-risk plaque features, and ischaemic recurrence characterizing premature coronary artery disease, but its volume, density, and relationship with plaque severity remained to be characterized.
Does epicardial adipose tissue volume and density differ in patients with premature coronary artery disease compared to matched controls, and does it correlate with plaque severity?
Does epicardial adipose tissue volume and density differ in patients with premature coronary artery disease compared to matched controls, and does it correlate with plaque severity?
Answers are grounded in this paper and cite their sources.
Increased epicardial adipose tissue volume and lower density on CT are imaging biomarkers associated with premature coronary artery disease and high-risk plaque features.
AIMS: Epicardial adipose tissue (EAT) could contribute to the specific atherosclerosis profile observed in premature coronary artery disease (pCAD) characterized by accelerated plaque burden (calcified and non-calcified), high-risk plaque (HRP) features, and ischaemic recurrence. Our aims were to describe EAT volume and density in pCAD compared with asymptomatic individuals matched on cardiovascular risk factors and to study their relationship with coronary plaque severity extension and vulnerability. METHODS AND RESULTS: Two hundred and eight patients who underwent coronary computed tomography angiography were analysed. It included 104 consecutive individuals with pCAD (acute or stable obstructive CAD before the age of 45 years) and 104 controls, matched 1:1 on age, sex, and cardiovascular risk factors. EAT volume, volume index (EATi), and density were measured with a semi-automated artificial-intelligence based segmentation method and CAD-RADS V2.0 determined according to guidelines. EAT volume and density were compared across groups, and associations with plaque burden and characteristics were investigated. EAT volume and EATi were significantly higher in patients with pCAD compared with matched controls (71.5 mL/m² [45.7;99.8] vs. 58.5 mL/m² [41.3;81.7] P = 0.002), and EAT density was significantly lower in patients with pCAD compared with matched controls (-82 HU [-87; -79] vs. -82 [-85; -78], P = 0.025). EATi was found to be positively correlated with increasing number of plaques, stenosis severity, and HRP features. CONCLUSION: Patients with pCAD had EAT expansion with a higher lipid concentration, compared with controls matched for traditional risk factors. Increased EAT volume and low EAT density were imaging biomarkers related to severe and potentially vulnerable CAD features.
No takes yet. Share an insight, caveat, or question.
Ritvo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: